Benzinga | Apr 19, 2021 08:03AM EDT

iCAD Highlights Presentation Of Data At Society Of Breast Imaging Symposium Apr. 9-11 And National Consortium Of Breast Centers Annual Interdisciplinary Breast Center Conference Apr. 16-19

iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that new research supporting the clinical value of ProFound AI(r) for Digital Breast Tomosynthesis (DBT) was presented at the Society of Breast Imaging (SBI) Symposium, April 9-11, and at the National Consortium of Breast Centers (NCBC) Annual Interdisciplinary Breast Center Conference (NCoBC), April 16-19.